Related Experiment Video
Updated: Oct 11, 2025
13:45
Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
10.1K
MCP-1 targeting: Shutting off an engine for tumor development.
Liang Wang1, Jinxin Lan2, Jiaping Tang2,3
1Department of Urology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
Oncology Letters
|December 6, 2021
Summary
Monocyte chemotactic protein-1 (MCP-1) plays a key role in tumor development by influencing invasion, metastasis, and immune cell infiltration. Targeting MCP-1 shows promise for novel cancer therapies.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Monocyte chemotactic protein-1 (MCP-1) is implicated in various diseases, including cancer.
- MCP-1 expression in the tumor microenvironment affects tumor invasion, metastasis, angiogenesis, and immune cell infiltration.
Purpose of the Study:
- To review the multifaceted role of MCP-1 in tumor development.
- To explore MCP-1's structure, signaling pathways, cellular interactions, and therapeutic targeting.
Main Methods:
- Literature review of studies on MCP-1 and cancer.
- Analysis of MCP-1's involvement in key oncogenic processes.
- Examination of therapeutic strategies targeting the MCP-1 pathway.
Main Results:
- MCP-1 influences tumor progression through the MCP-1/C-C motif chemokine receptor 2 axis.
- Activation of signaling pathways like PI3K/Akt/mTOR and MAPK by MCP-1.
- Neutralizing MCP-1 antibodies demonstrate a negative impact on tumor development.
Conclusions:
- Understanding MCP-1's structure and mechanisms is crucial for developing effective cancer therapies.
- Targeting MCP-1 offers a promising strategy for improving cancer treatment outcomes.
Related Concept Videos
02:23Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
02:17The Tumor Microenvironment
6.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.9K
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K